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Archived neonatal blood cards (Guthrie cards) from children who later contracted leukaemia and matched normal controls were
assayed for adenovirus (AdV) C DNA content using two highly sensitive methods. In contrast to a previous report, AdV DNA was
not detected at a higher frequency among neonates who later developed leukaemia, when compared with controls.
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The causes of childhood acute lymphoblastic leukaemia (ALL),
the most common type of paediatric cancer in developed
countries, remain unclear. Greaves et al hypothesised that the
malignant transformation of a normal cell to leukaemia requires
two separate events (Greaves, 1999; Wiemels et al, 1999; Mori et al,
2002; Greaves et al, 2003). The first event would occur in utero
producing a pre-leukaemic clone, and a secondary postnatal
event is required for this clone to expand into full-blown disease.
Either the pattern of normal childhood infections (the ‘delayed-
infection’ hypothesis; Greaves, 1988) or specific infectious
organisms (the ‘population mixing’ hypothesis; Kinlen, 1988) are
most likely important modifiers of one or both of these events.
Concerning the first event, one potential mechanism might involve
a transforming response following maternal transmission of
infection to the fetus. In this model, the infection in the fetus
could induce a genomic instability favouring the onset of
chromosomal aberrations or other mutations (Smith, 1997;
Smith et al, 1997).
Molecular screening for specific candidate viruses or virus
families has produced negative results (as reviewed by Greaves,
2006). Representative difference analysis (RDA) has been used to
screen for anonymous, non-human sequences in the genome of
common ALL (cALL) samples and no foreign sequences were
detected (Mackenzie et al, 2006). In addition, degenerate PCR
screens have not implicated a higher frequency of infection in
leukaemia cells than in blood cells from children without
leukaemia (MacKenzie et al, 2001). These data seem to provide
evidence against direct viral transformation. These approaches are
not infallible; however, it is possible that a very small virus or
proviral component might be involved or that a transforming virus
has operated through a ‘hit-and-run’ mechanism.
Human adenoviruses (AdVs) cause various common diseases
in adults and children such as conjunctivitis, respiratory infections
and diarrhoea (Wadell, 1984). Although AdV infections have
never been convincingly linked to human oncogenesis, the
transforming properties of human AdVs are well documented in
animal models (Endter and Dobner, 2004). Nevels et al (2001)
showed that AdV infections may contribute to the development of
some human tumours through a mutagenesis-based hit-and-run
mechanism resulting in tumours that do not carry viral genes
and proteins. Other possible mechanism by which AdV could
transform by a ‘hit-and-run’ mechanism is suggested by its
stimulatory effects on DNA methyltransferase 1 (DNMT1)
(Burgers et al, 2007) and the profound DNA methylation changes
that occur in rodent AdV cancer models (Doerfler, 2006). Data
indicating a possible role of AdVs in human oncogenesis are
restricted to the investigation of serotype 5 (a C class virus), and
little is known about the oncogenic potential of other members of
the AdV family. Recently, the first evidence for the possible
contribution of AdV to the multistep process of tumour
pathogenesis was shown in some paediatric tumour entities but
not leukaemia (Kosulin et al, 2007).
A provocative recent report (Gustafsson et al, 2007)
demonstrated an increased frequency of group-C AdV in Guthrie
cards from children who developed ALL. This was the first
description of a very high frequency of viral DNA present in
Guthrie cards, and this same group found no other viral DNAs in
previous Guthrie card studies (Priftakis et al, 2003; Bogdanovic
et al, 2004; Isa et al, 2004; Gustafsson et al, 2006). As AdV
DNA was found only in 2 out of 130 leukaemia tumour samples in
one report (Kosulin et al, 2007), a hit-and-run mechanism
is the only likely possibility. In this study, we sought to confirm
the Guthrie card screening result in a patient population
in California.
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sMATERIALS AND METHODS
Patients
Guthrie cards from 89 children who later developed acute
lymphocytic leukaemia and 100 healthy children were screened.
Cards were obtained from a single centralized repository where
they were stored dry at  201C. The leukaemia cases, from which
the 89 Guthrie cards were derived, were selected from a
population-based case series: the Northern California Childhood
leukaemia study (Chang et al, 2006). The leukaemia patients were
between 1 month and 14 years of age at diagnosis; median of 4
years old. Controls were derived from the same population as the
cases and matched by birthdates, gender, ethnicity and geographic
region of birth; therefore, with the same age range and median age
as the cases. Written informed consent was obtained from all case
and control parents, and all studies were reviewed and approved
by the appropriate institutional review boards.
DNA extraction from Guthrie cards
A one-eighth portion of a 1.5cm
2 card was cut and DNA was isolated
with QIAamp Micro Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. This represents approximately 150ng of
DNA or 25000 cells. The samples were quantified using PicoGreen
DNA quantification reagent (Invitrogen, Carlsbad, CA, USA).
Real-time quantitative PCR
Quantitative analysis of Guthrie card DNA was performed using
real-time quantitative PCR for AdV hexon gene as described
previously (Ebner et al, 2005) with slight modifications. Briefly,
three different primer/probe systems were used to detect Adv
species A, C and F in one single reaction. Polymerase chain
reactions were set up in a total volume of 20ml, including 1 
TaqMan Universal Master Mix (Applied Biosystems, Foster City,
CA, USA), 0.2mM probes, 0.3 or 0.9mM of primers and 20 or 50ng
of template DNA. The TaqMan probes used were labelled with 6-
carboxyfluorescein at the 50-end and with blackhole quencher at
the 30-end (MWG Biotech Inc., Huntsville, AL, USA). Amplifica-
tions were carried out using the ABI Prism 7900 HT (Applied
Biosystems) for a total of 50 cycles. After an initial denaturation
step for 10min at 951C, each cycle consisted of denaturation for
15s at 951C and annealing and primer extension for 60s at 601C.
Strict precautions were undertaken to prevent contamination of
PCRs with exogenous products. To reduce the risk of false-positive
results due to contamination with PCR products, dTTP was
partially replaced by dUTP in the reaction master mixture and a
dUTP glycosylase step was performed before each PCR. Each DNA
patient sample was analysed in duplicate, standard dilutions of
AdV-5 were run in quadruplicates and negative controls were
included in each assay. DNA derived from AdV type 5 (AdV-5)
(cat. no. 7K0013, Advanced Biotechnologies Inc., Columbia, MD,
USA) served as a quantitated positive control. For the quantifica-
tion of virus copies, external standard curves were established
using 10-fold serial dilutions of quantified virus DNA preparations
corresponding to defined virus particle equivalents. As a separate
internal control, we used an Alu element-based assay, which
amplifies the Intra-Yd6 sequence of human DNA (Hansen et al,
2007).
Semi-nested PCR
The AdV fiber gene (a polymorphic gene that can be used to
distinguish AdV species) was screened in Guthrie card samples by
using semi-nested PCR. The PCR amplifications were carried
out in a final volume of 50ml consisting of 1  PCR buffer,
2.25mM MgCl2,0 . 2m M each deoxynucleosidetriphosphate (Applied
Biosystems), 2.5U of Taq Gold polymerase (Applied Biosystems),
150nM each primer (Garnett et al, 2002) and 20ng of template DNA.
Polymerase chain reaction amplification was carried out with 1 cycle
at 951Cf o r4m i n ,3 5c y c l e so f9 5 1C for 45s, 561C for 45s and 721C
for 45s, followed by 1 cycle at 721C for 3min. Following the initial
cycle of PCR, 1ml of primary PCR product was used in a second
amplification. The second PCR amplification was done for 25 cycles.
Polymerase chain reaction products were visualised on a 1.8%
agarose gel stained with ethidium bromide. The fiber primary PCR
product was 408bp, and the semi-nested PCR product was 175bp.
RESULTS
Eighty of the 89 cases had B-precursor ALL and a typical pattern of
cytogenetic rearrangements (Table 1). Six patients had T-cell ALL,
with three being indeterminate or biphenotypic (Table 1).
Sensitivity of the assays
The lower detection limit of the molecular tests described was
assessed by the analysis of dilution series (ranging from 0.1 to
10
4copies) prepared using quantified viral DNA derived from the
reference strain (AdV-5). Reproducible quantification of virus
copies was obtained by RQ–PCR in the presence of 1–10
4 particles
per reaction (Figure 1). When the threshold cycle values of the
standard dilutions were plotted against the log10 of the starting
copy number, the correlation coefficient values were higher than
0.990 and the slope of the line was lower than  3.34, indicating an
amplification efficiency of 99–100%. With the nested PCR, the
detection limit was higher. Positive results were obtained with
starting quantity as low as 0.1 viral copy (Figure 2).
RQ–PCR
DNA samples from 40 ALL patients and from 56 normal controls
were analysed for the presence of AdV subgroup A, C and F DNA
by real-time PCR, which is slightly less sensitive than the nested
assay. The degree of homology of AdV subgroups permitted the
establishment of a single RQ–PCR covering all serotypes of the
species A, C and F (Ebner et al, 2005). Individual samples were
assayed two times, on separate occasions. In the first set of
reactions, 20ng of each DNA sample (n¼96) was run in duplicate.
Table 1 Characteristics of leukaemia cases whose Guthrie cards were
tested for the presence of adenovirus
Patient characteristics N AdV DNA
Controls 100 1
Cases 89 0
Bp ALL 80
T ALL 6
Unknown lineage 3
Karyotype
a
Hyperdiploid (47–50) 12
Hyperdiploid (51–67) 27
Triploid 2
Pseudodiploid 27
t(12;21) 13
chr11q2.3 8
Others 4
No abnormality 9
AdV¼adenovirus; ALL¼ acute lymphoblastic leukaemia; Bp ALL¼B-cell precursor
ALL; T ALL¼T-cell ALL.
aAmong Bp ALL only. Characteristics of T-cell ALL are not
shown.
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sThen, a second set was run, with 50ng of each DNA sample
(n¼78) also in duplicate. None of the samples contained
detectable AdV DNA, and all samples amplified for Yd6 control
gene at a level consistent with the amount of DNA added (Hansen
et al, 2007). There was no relationship between the age of the card
(i.e., the age of the child) and the ease of amplification of this
control gene. Owing to the negative results with this method, we
moved to the two-round nested PCR approach.
Semi-nested PCR
Nested PCRs were carried out with DNA samples from 89 ALL
patients and from 100 normal controls for detection of the fiber
gene. The primers used in these reactions were designed to amplify
all serotypes of the AdV subgroup C (Garnett et al, 2002). Only one
of the 189 samples contained amplifiable AdV DNA (Figure 3) and
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Figure 1 Real-time PCR standardisation of AdV ACF reaction. (A) Standard curve plot of the 10-fold serial dilution of AdV-5. Linearity is observed
throughout the range from 1 to 10
4 copies per reaction. (B) Amplification curves of the hexon gene with AdV-5 control DNA. The control DNA is a
certified quantified standard.
1234567 891 0 1 1 1 2 1 3
Figure 2 Detection of the fiber gene of AdV C genome by nested PCR.
Serial 10-fold dilutions of the control DNA, ranging from 0.1 copy to
10
3copies of the genome were used in the first reactions. Lane 1, molecular
weight marker (100bp); lanes 2–6, first round of amplification (0.1, 1, 10,
100 and 1000 copies, respectively); lanes 8–12, semi-nested amplification
of the dilution series only; and lanes 7 and 13, negative controls.
1 2 3 4 5 6 7 8 9 1 01 11 21 31 41 51 61 71 8
Figure 3 Detection of fiber gene of AdV-C by nested PCR in ALL
samples. Results from the nested (second round) PCR are shown. Lane 1,
100bp molecular weight marker; lanes 2–8 and 10–17, negative samples;
lane 9, positive sample; and lane 18, positive control AdV-5.
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sit belonged to a normal control subject. It is likely that this sample
carries very low AdV particle number, as it did not amplify by
RQ–PCR.
DISCUSSION
It has been suggested that infection in utero with a virus that has
an oncogenic potential could be involved in the initiation of ALL,
by inducing genomic instability in B-lymphocytes. As AdV is a
common infection in intrauterine environments (Van den Veyver
et al, 1998; Baschat et al, 2003), and expression of the E1A and E1B
oncogenes of AdV-5 may transform normal cells into a
tumorigenic phenotype (Nevels et al, 2001), this virus could
potentially be involved in the initial event promoting leukaemia. In
this study, human AdV DNA subtypes A, C or F was not detected
by PCR in the blood from Guthrie cards neither in children who
had developed ALL (n¼89) nor from healthy controls (n¼99),
except for one normal control sample. These results demonstrate a
lower rate of positivity (B0.5%) than that found for AdV in
amniocentesis samples from the second trimester of normal
pregnancies (B5%; Baschat et al, 2003). Exposure and infection
to AdV in utero is then likely more common than would be
indicated by the current results; however, it makes sense that AdV
type C would be less likely to be found in blood, as its natural
tropism is respiratory epithelium. The virus is normally shed
through stool and therefore could be deposited in amniotic fluid
when a fetus is infected. All of our DNA samples contained
amplifiable DNA at amounts that correlated with Pico-green assays
when tested by Alu-element Yd6; therefore, PCR inhibitors do not
cause our negative results from the Guthrie cards. Recently,
Gustafsson et al (2007), using similar methodology (nested PCR
and RQ–PCR) that we used in this study, showed a very high
frequency of AdV group C-positive samples in ALL patients (27%)
when compared with controls (6%). Unless the Swedish mothers
are exposed to very different environmental and genetic factors
that influence transmission of infection to a fetus and detection in
blood, when compared with pregnant woman in California, there is
no obvious explanation for this discrepancy. As sero- and
molecular positivity to AdV C are not significantly higher in
Swedish compared with USA populations (Ostlund et al, 2004;
Arnold et al, 2008), we do not think that there are population
differences in exposure and fetal transmission; rather the results of
Gustafsson may be on tha basis of laboratory issues that are
difficult to evaluate given the limited data provided (Gustafsson
et al, 2007). The differences between the two studies may also arise
from concurrent exposures that might increase infectivity of the
virus in Sweden including smoking habits or respiratory diseases.
Our results, presented here with positive and negative controls and
a certified DNA standard, are defensible as negative, and we do not
encourage further research into the detection of AdV in Guthrie
cards for the purposes of studying leukaemia aetiology, at least in
California.
Speculations concerning a link between infections and child-
hood leukaemia have been published for decades and, despite a
multitude of epidemiological correlations, a definitive mechanistic
explanation remains elusive. The absence of any viral DNA in
Guthrie cards does not constitute negative evidence of the role of
infections in leukaemia aetiology if the critical exposure is post-
natal. The early postnatal period is the time period with the
strongest epidemiological evidence concerning a link between
infectious disease history and childhood leukaemia (Greaves,
2006). The absence of AdV DNA in Guthrie cards does not rule out
a hit-and-run mechanism of this virus; its lack of detection in
Guthrie cards in this study argues only against a role of this virus
in prenatal infection. Future studies may examine the role of AdV
and other specific viruses in the mother’s and child’s life. To date,
however, strong evidence for specific viral involvement in child-
hood leukemogenesis is quite limited, compared with the
large body of strong evidence linking immune modulation
through unspecified common childhood infections as a protective
factor.
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